Research Article
Identification of Gene Markers for Survival Prediction of Lung Adenocarcinoma Patients Based on Integrated Multibody Data Analysis
Table 1
Clinicopathological characteristics of patients with lung adenocarcinoma.
| | Clinicopathological characteristics | Survival (%)
| Death (%)
| Median survival time (months) | HR (95% CI) | value |
| | Age (year) | | | | | | | ≤65 | 153 (44.92) | 49 (35.00) | 24.65 | 1 | 0.23 | | >65 | 187 (55.08) | 91 (65.00) | 21.36 | 1.32 (0.85~1.94) | | Gender | | | | | | | Male | 206 (60.58) | 64 (45.71) | 21.65 | 1 | 0.45 | | Female | 134 (39.42) | 76 (54.29) | 26.35 | 1.07 (0.72~1.65) | | Smoking status | | | | | | | Yes | 48 (14.12) | 18 (12.86) | 26.48 | 1 | 0.78 | | No | 292 (85.88) | 122 (87.14) | 23.89 | 0.91 (0.48~1.76) | | TNM staging | | | | | | | I-II | 294 (86.05) | 95 (67.86) | 28.94 | 1 | 0.01 | | III-IV | 46 (13.50) | 45 (32.14) | 12.36 | 2.83 (1.88~4.25) |
|
|
HR: hazard ratio; TNM: tumor node metastasis; CI: confidence interval; . |
